Aktie A2PNS7 MUSTGROW BIOLOGICS CORP.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen MustGrow Biologics Corp. Canadian Securities Exchange

Aktien

A2PNS7

CA62822A1030

MGRO

Verzögert Canadian Securities Exchange
Andere Börsenplätze
 		% 5 Tage % 1. Jan.
- CAD -.--% Intraday Chart für MustGrow Biologics Corp. +6.74% -28.57%
2023 Mustgrow Biologics Corp. gibt die Unterzeichnung eines Kooperationsabkommens mit der Bayer AG bekannt CI
2023 MustGrow Biologics Corp. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
MustGrow Biologics to Present at the Planet MicroCap Showcase
MustGrow Receives Registration Approval for TerraSante(TM) in Oregon State
MustGrow Biologics Corp.(TSXV:MGRO) dropped from S&P/TSX Venture Composite Index
MustGrow Provides Additional Information and Clarification on Commercial License Agreement with Bayer
MustGrow Biologics agrees to commercial licence agreement with Bayer covering Europe, Middle East and Africa
Mustgrow Biologics Corp. Announces the Signing of Collaboration Agreement with Bayer AG
MustGrow Biologics and Bayer Sign Commercial License Agreement for Biocontrol Technologies in Europe, Middle East and Africa
MustGrow Biologics Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
MustGrow Biologics announces company has received approval for TerraSante in Washington State
MustGrow Biologics Corp. Receives Registration Approval for TerraSante in Washington State
MustGrow Receives Registration Approval for TerraSante(TM) in Washington State
MustGrow to Present at the Harbor Access Global SMID Cap Investor Conference November 16th
MustGrow Biologics Corp. Receives PMRA Approval to Commence Large Scale Field Trials via NexusBioAg BAT Program
MustGrow Receives PMRA Approval to Commence Large Scale Field Trials via NexusBioAg BAT Program
MustGrow Biologics announces Terrasante fertilizer granted USDA organic approval
MustGrow Biologics Corp. Receives USDA Organic Approval for Biological Fertilizer and Soil Amendment Technology
MustGrow Receives USDA Organic Approval for Biological Fertilizer and Soil Amendment Technology
MustGrow Announces Participation at Biocontrol Industry Conference and Investor Webinar
MustGrow Announces Investor Relations Agreement with Harbor Access
MustGrow Biologics : September Presentation
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2PNS7 Aktie
  4. A2PNS7 Aktie
  5. Nachrichten MustGrow Biologics Corp.
  6. Andere Sprachen